0001256071-24-000003.txt : 20240212
0001256071-24-000003.hdr.sgml : 20240212
20240212183507
ACCESSION NUMBER: 0001256071-24-000003
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240212
DATE AS OF CHANGE: 20240212
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: KAZIA THERAPEUTICS LTD
CENTRAL INDEX KEY: 0001075880
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: C3
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-50612
FILM NUMBER: 24621891
BUSINESS ADDRESS:
STREET 1: THREE INTERNATIONAL TOWERS LEVEL 24,
STREET 2: 300 BARANGAROO AVENUE
CITY: SYDNEY NSW
STATE: C3
ZIP: 2000
BUSINESS PHONE: 01161298780088
MAIL ADDRESS:
STREET 1: THREE INTERNATIONAL TOWERS LEVEL 24,
STREET 2: 300 BARANGAROO AVENUE
CITY: SYDNEY NSW
STATE: C3
ZIP: 2000
FORMER COMPANY:
FORMER CONFORMED NAME: NOVOGEN LTD
DATE OF NAME CHANGE: 19981228
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: PLATINUM INVESTMENT MANAGEMENT LTD
CENTRAL INDEX KEY: 0001256071
ORGANIZATION NAME:
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: C/O PLATINUM ASSET MANAGEMENT
STREET 2: LEVEL 8, 7 MACQUARIE PLACE
CITY: SYDNEY AUSTRALIA 2000
STATE: C3
ZIP: 00000
BUSINESS PHONE: 61292557533
MAIL ADDRESS:
STREET 1: C/O PLATINUM ASSET MANAGEMENT
STREET 2: LEVEL 8, 7 MACQUARIE PLACE
CITY: SYDNEY AUSTRALIA 2000
STATE: C3
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: PLATINUM ASSET MANAGEMENT LTD
DATE OF NAME CHANGE: 20030722
SC 13G
1
KaziaTherapeutics11.txt
SC 13G
Schedule 13G
Name of issuer: Kazia Therapeutics Ltd
Title of class of securities: Sponsored ADR
Cusip: 48669G105
Date of event which requires filing: 12/31/2023
Rule 13d-1(b)
1. Platinum Investment Management Limited
2. (b)
3.
4. Sydney Australia
5. Platinum Investment Management Limited
1,821,887 (6.91%)
Note:Combined total of underlying managed funds
6. N/A
7. Platinum Investment Management Limited
1,821,887 (6.91%)
Note:Combined total of underlying managed funds
8. N/A
9. 1,821,887
10. No
11. 6.91%
12. IA
Item 1.
(a) Kazia Therapeutics Ltd
(b) Three International Towers,
Level 24, 300 Barangaroo Avenue,
SYDNEY, NSW, Australia, 2000
Item 2.
(a) Platinum Investment Management Limited
(b) Level 8, 7 Macquarie Place
Sydney NSW 2000
Australia
(c) Australia
(d) Sponsored ADR
(e) 48669G105
Item 3.
(e) An IA in accordance with Section 240.13d-1(b)(1)(ii)(e)
Item 4.
(a) 1,821,887
(b) 6.91%
(c) (i) 1,821,887
(ii) 0
(iii) 1,821,887
(iv) 0
Item 5
No
Item 6
The clients of Platinum Investment Management Ltd including pooled
investment vehicles and other managed accounts have the right to
receive or power to direct the receipt of dividends from, and the
proceeds from the sale of, Kazia Therapeutics Ltd.
Item 7
N/A
Item 8
N/A
Item 9
N/A
Item 10
(a) By signing below, I certify that to the best of my knowledge and
belief, the securities referred to above were acquired and are held
in the ordinary course of business and were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
(b) N/A
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information
set forth in this statement is true, complete and correct.